Utilizing an acute hyperthermia-induced seizure test and pharmacokinetic studies to establish optimal dosing regimens in a mouse model of Dravet syndrome

被引:3
作者
Mensah, Jeffrey A. [1 ]
Johnson, Kristina [2 ]
Freeman, Tia [3 ]
Reilly, Christopher A. [1 ,3 ]
Rower, Joseph E. [1 ,3 ]
Metcalf, Cameron S. [1 ,2 ]
Wilcox, Karen S. [1 ,2 ]
机构
[1] Univ Utah, Dept Pharmacol & Toxicol, Salt Lake City, UT USA
[2] Contract Site Natl Inst Neurol Disorders & Stroke, Salt Lake City, UT USA
[3] Ctr Human Toxicol, Salt Lake City, UT USA
基金
美国国家卫生研究院;
关键词
antiseizure drugs; Dravet syndrome; hyperthermia-induced seizure model; pharmacokinetics; triple-drug therapy; ANTIEPILEPTIC DRUGS; VALPROIC ACID; CANNABIDIOL; STIRIPENTOL; CHILDREN; CANNABINOIDS; INHIBITION; CLOBAZAM; EFFICACY; EPILEPSY;
D O I
10.1111/epi.18104
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
ObjectiveThe current standard of care for Dravet syndrome (DS) includes polytherapy after inadequate seizure control with one or more monotherapy approaches. Treatment guidelines are often based on expert opinions, and finding an optimal balance between seizure control and adverse drug effects can be challenging. This study utilizes the efficacy and pharmacokinetic assessment of a second-line treatment regimen that combines clobazam and sodium valproate with an add-on drug as a proof-of-principle approach to establish an effective therapeutic regimen in a DS mouse model.MethodsWe evaluated the efficacy of add-on therapies stiripentol, cannabidiol, lorcaserin, or fenfluramine added to clobazam and sodium valproate against hyperthermia-induced seizures in Scn1aA1783V/WT mice. Clobazam, N-desmethyl clobazam (an active metabolite of clobazam), sodium valproate, stiripentol, and cannabidiol concentrations were quantified in plasma and brain using liquid chromatography-tandem mass spectrometry for the combinations deemed effective against hyperthermia-induced seizures. The concentration data were used to calculate pharmacokinetic parameters via noncompartmental analysis in Phoenix WinNonLin.ResultsHigher doses of stiripentol or cannabidiol, in combination with clobazam and sodium valproate, were effective against hyperthermia-induced seizures in Scn1aA1783V/WT mice. In Scn1aWT/WT mice, brain clobazam and N-desmethyl clobazam concentrations were higher in the triple-drug combinations than in the clobazam monotherapy. Stiripentol and cannabidiol brain concentrations were greater in the triple-drug therapy than when given alone.SignificanceA polypharmacy strategy may be a practical preclinical approach to identifying efficacious compounds for DS. The drug-drug interactions between compounds used in this study may explain the potentiated efficacy of some polytherapies. Illustration of study design.image
引用
收藏
页码:3100 / 3114
页数:15
相关论文
共 55 条
[1]   Cannabis constituents interact at the drug efflux pump BCRP to markedly increase plasma cannabidiolic acid concentrations [J].
Anderson, Lyndsey L. ;
Etchart, Maia G. ;
Bahceci, Dilara ;
Golembiewski, Taliesin A. ;
Arnold, Jonathon C. .
SCIENTIFIC REPORTS, 2021, 11 (01)
[2]   Coadministered cannabidiol and clobazam: Preclinical evidence for both pharmacodynamic and pharmacokinetic interactions [J].
Anderson, Lyndsey L. ;
Absalom, Nathan L. ;
Abelev, Sarah V. ;
Low, Ivan K. ;
Doohan, Peter T. ;
Martin, Lewis J. ;
Chebib, Mary ;
McGregor, Iain S. ;
Arnold, Jonathon C. .
EPILEPSIA, 2019, 60 (11) :2224-2234
[3]   Unexpected Efficacy of a Novel Sodium Channel Modulator in Dravet Syndrome [J].
Anderson, Lyndsey L. ;
Hawkins, Nicole A. ;
Thompson, Christopher H. ;
Kearney, Jennifer A. ;
George, Alfred L., Jr. .
SCIENTIFIC REPORTS, 2017, 7
[4]   DENSITY OF TISSUES IN AND ABOUT HEAD [J].
BARBER, TW ;
BROCKWAY, JA ;
HIGGINS, LS .
ACTA NEUROLOGICA SCANDINAVICA, 1970, 46 (01) :85-&
[5]  
Buck ML., 2018, Pediatr Pharm, V24, P1
[6]   Therapeutic strategy in severe encephalopathies [J].
Campos-Castelló, J .
REVISTA DE NEUROLOGIA, 2001, 32 (09) :860-866
[7]   Guidance on Dravet syndrome from infant to adult care: Road map for treatment planning in Europe [J].
Cardenal-Munoz, Elena ;
Auvin, Stephane ;
Villanueva, Vicente ;
Cross, J. Helen ;
Zuberi, Sameer M. ;
Lagae, Lieven ;
Aibar, Jose Angel .
EPILEPSIA OPEN, 2022, 7 (01) :11-26
[8]   Lack of interactions between breast cancer resistance protein (BCRP/ABCG2) and selected antiepileptic agents [J].
Cerveny, L ;
Pavek, P ;
Malakova, J ;
Staud, F ;
Fendrich, Z .
EPILEPSIA, 2006, 47 (03) :461-468
[9]   Valproic acid induces CYP3A4 and MDR1 gene expression by activation of constitutive androstane receptor and pregnane X receptor pathways [J].
Cerveny, Lukas ;
Svecova, Lucie ;
Anzenbacherova, Eva ;
Vrzal, Radim ;
Staud, Frantisek ;
Dvorak, Zdenek ;
Ulrichova, Jitka ;
Anzenbacher, Pavel ;
Pavek, Petr .
DRUG METABOLISM AND DISPOSITION, 2007, 35 (07) :1032-1041
[10]   Severe myoclonic epilepsy in infancy: Toward an optimal treatment [J].
Ceulemans, B ;
Boel, M ;
Claes, L ;
Dom, L ;
Willekens, H ;
Thiry, P ;
Lagae, L .
JOURNAL OF CHILD NEUROLOGY, 2004, 19 (07) :516-521